Fax completed prior authorization request form to 800-854-7614 or submit Electronic Prior Authorization through
CoverMyMeds® or SureScripts.
All requested data must be provided. Incomplete forms or forms without the chart notes will be returned
Pharmacy Coverage Guidelines are available at
www.mercycareaz.org/providers/completecare-forproviders/pharmacy
Entresto
Pharmacy Prio
r Authorization
Request Form
Do not copy for future use. Forms are updated frequently.
REQUIRED: Office notes, labs and medical testing relevant to request showing medical justification to support diagnosis
Member Name (first & last):
Prescribing Provider Information
Provider Name (first & last):
Dispensing Pharmacy Information
Requested Medication Information
Medication request is NOT for an FDA- approved, or
compendia-supported diagnosis (circle one): Yes No
Are there any contraindications to formulary medications?
If yes, please specify:
request
Continuation of therapy
ONLY:
Was there response to treatment?
Was Entresto used with other HF therapies (BB, aldosterone antagonist OR
combination therapy with hydralazine AND isosorbide dinitrate)?
Is member a female AND of childbearing age?
Was combination therapy with hydralazine AND isosorbide dinitrate used?
What medication(s) has member tried and failed for this diagnosis? Please specify below.
Turn-Around Time for Review
Urgent – waiting 24 hours for a standard decision could seriously harm life, health,
or ability to regain maximum function, you can ask for an expedited decision.
Signature:
_____________________________________________________
Will medication be used concomitantly OR within 36
hours of last dose of ACEI OR medication
containing aliskiren (Tekturna OR Tekturna-HCTZ)?
Does member have severe hepatic
impairment (Child Pugh Class C) AND
Is member a female AND of childbearing age?
Members Ages 18 Years OR Older
Does member have NYHA Class II-IV chronic HF with reduced ejection fraction ≤40%?
Is member tolerating an ARB OR an ACEI?
Will Entresto replace the ARB and/or
ACEI?
Will Entresto be used in conjunction with other HF therapies (beta blockers, aldosterone antagonist OR combination
therapy with hydralazine AND isosorbide dinitrate)?
Members Ages 1 Year OR Older
Does member have symptomatic HF and
systemic left ventricular systolic dysfunction?
Has member tried AND failed enalapril?
Additional information the prescribing provider feels is important to this review. Please specify below or submit medical records.
Effective: 06/08/2020 C9614-C 02-2020 Page 1 of 2
click to sign
signature
click to edit